Ingevity Analyst Ratings
Ingevity Price Target Raised to $47.00/Share From $40.00 by BMO Capital
Ingevity Is Maintained at Market Perform by BMO Capital
BMO Capital Maintains Ingevity(NGVT.US) With Hold Rating, Cuts Target Price to $40
Wells Fargo Maintains Ingevity(NGVT.US) With Hold Rating, Maintains Target Price $40
Wells Fargo Maintains Ingevity(NGVT.US) With Hold Rating, Maintains Target Price $40
Wells Fargo Maintains Ingevity(NGVT.US) With Hold Rating, Cuts Target Price to $40
Ingevity's Leadership Transition: Navigating Uncertainties and Maintaining a Hold Rating
Jefferies Maintains Ingevity(NGVT.US) With Buy Rating, Maintains Target Price $53
Ingevity Is Maintained at Market Perform by BMO Capital
Ingevity Analyst Ratings
Jefferies Maintains Ingevity(NGVT.US) With Buy Rating, Cuts Target Price to $53
Ingevity (NGVT) Gets a Buy From Jefferies
BMO Capital Maintains Market Perform on Ingevity, Lowers Price Target to $42
BMO Capital Maintains Ingevity(NGVT.US) With Hold Rating, Cuts Target Price to $42
Ingevity (NGVT) Receives a Hold From Wells Fargo
Ingevity Analyst Ratings
Oppenheimer Adjusts Ingevity Price Target to $50 From $58, Maintains Outperform Rating
Ingevity Analyst Ratings
Oppenheimer Maintains Ingevity(NGVT.US) With Buy Rating, Cuts Target Price to $50
No Data
No Data